Podcasts about Psychopharmacology

In this episode, Dr. Andy Cutler sits down with Dr. Debbi Morrissette, Senior Director of Educational Development at NEI, to explore the magic behind NEI Congress. Tune in as they talk about the unique elements of NEI Congress that bring the visual language of psychopharmacology to life!  Are you ready to step up your clinical game? Join us at the 2025 NEI Fall Congress, Nov. 6–9 in Colorado Springs (or online via simulcast)! Explore a comprehensive program of psychopharmacology essentials: treatments, side effects, drug interactions, and more — all taught by top-tier faculty.  Special Offer for NEI Podcast Listeners: Register now and save $50 off your registration with code POD25FALL   Register today at https://nei.global/fall  Never miss an episode!

In this explosive and highly anticipated episode, Dr. Roger McFillin hosts Dr. Ragy Girgis, a Columbia University Professor of Psychiatry and researcher, for a no-holds-barred confrontation that exposes the shocking divisions tearing apart the mental health field. What begins as a conversation about mass violence research rapidly explodes into a devastating examination of psychiatric medicine's crumbling foundations, questionable effectiveness, and devastating potential harms. The two clash in fierce, unrelenting disagreements over fundamental issues including the validity of DSM diagnoses, the debunked "chemical imbalance" theory of depression, dangerous SSRI safety cover-ups and black box warnings, corrupted research quality and pharmaceutical industry manipulation, and the catastrophic crisis of psychiatric drug overprescription poisoning 1 in 4-5 Americans. Dr. Girgis desperately defends traditional academic psychiatry and current treatment approaches, while Dr. McFillin ruthlessly dismantles the entire paradigm, arguing that the current system is systematically creating chronic mental illness rather than healing it. Buckle up for this brutal intellectual warfare.___________________________________________________________________________________________________________________________________________________Throughout the interview, Dr. Girgis repeatedly stated that "the data is clear" while dismissing contradictory evidence that challenges his conclusions. For our listeners' benefit, I have compiled research and documentation that directly disputes several of Dr. Girgis's key claims.Serotonin Hypothesis of Depression1. The serotonin theory of depression: a systematic umbrella review of the evidence (Moncrieff et al.)Conclusions: "This review suggests that the huge research effort based on the serotonin hypothesis has NOT produced convincing evidence of a biochemical basis to depression. This is consistent with research on many other biological markers . We suggest it is time to acknowledge that the serotonin theory of depression is NOT empirically substantiated."2.What has serotonin to do with depression?Conclusions: "Simple biochemical theories that link low levels of serotonin with depressed mood are no longer tenable."3. Is the chemical imbalance an ‘urban legend'? An exploration of the status of the serotonin theory of depression in the scientific literatureViolence & Suicide Associated with SSRI's 1. Precursors to suicidality and violence on antidepressants: systematic review of trials in adult healthy volunteers2. Prescription Drugs Associated with Reports of Violence Towards Others3. Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family4. Lexapro Approved for Pediatric Use Despite the 6-Fold Increase in Suicide Risk5. McFillin Substack Review on Lexapro approved despite Suicide Risk6. Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports7. Antidepressants Increase Suicide Attempts in Youth; No Preventative Effect8. Effect of selective serotonin reuptake inhibitor treatment following diagnosis of depression on suicidal behaviour risk:9.  FDA Warning: Antidepressants increase the risk of suicidal thinking and behavior (suicidality) in children and adolescents10.  Suicide Mortality in the United States, 2001–2021 CDC documentation11. US suicide rate reaches highest point in more than 80 years: See what latest data shows12.  CNN article reporting Eli Lilly Internal Documents"An internal document purportedly from Eli Lilly and Co. made public Monday appears to show that the drug maker had data more than 15 years ago showing that patients on its antidepressant Prozac were far more likely to attempt suicide and show hostility than were patients on other antidepressants and that the company attempted to minimize public awareness of the side effects. The 1988 document indicated that 3.7 percent of patients attempted suicide while on the blockbuster drug, a rate more than 12 times that cited for any of four other commonly used antidepressants.In addition, the paper said that 1.6 percent of patients reported incidents of hostility -- more than double the rate reported by patients on any of four other commonly used antidepressants."Examples of Violence after Prescription in legal system (Sample)January 24, 2020 – Newcastle, South Dublin, Ireland: Deirdre Morley, 44, smothered and killed her two sons Conor, 9, and Darragh, 7, and her three-year-old daughter Carla McGinley in their family home. She had been taking antidepressants since October 2018 and was admitted to St. Patrick's Mental Health Services on July 6, 2019, but was discharged after a short period, but was put on a combination of two antidepressants and a sedativeMay 11, 2018 – Osmington, Western Australia: Peter Miles, 61, shot his 35-year-old daughter and four grandchildren, aged 8 through 13, while they slept in their beds, in a shed that had been converted to a second house on the property. He then turned the gun on his 58-year-old wife in the living room of their house, before placing a call to police alerting them to his crimes. When they arrived, Miles was also found dead from a gunshot wound. Miles had started taking antidepressant medication just weeks before.April 6, 2018 – Wadsworth, Ohio: Gavon Ramsay, 17, strangled his neighbor, 98-year-old Margaret Douglas in her own home. His parents blame his actions on his having been misprescribed Zoloft. After a report by his school principal that the teen was depressed and might harm himself, he “returned to therapy,” and after a recommendation by a psychologist, the family's pediatrician prescribed the antidepressant Zoloft. From January through March leading up to the incident, the dosages were increased. During this time, his mother said she observed her son's behavior change—becoming increasingly irritable and hostile and saying bizarre things.October 21, 2013 – Sparks, Nevada: 12-year-old Jose Reyes opened fire at Sparks Middle School, killing a teacher and wounding two classmates be...

In this episode, Dr. Andy Cutler and Dr. Jeffrey Strawn explore the complexities of obsessive-compulsive disorder (OCD). Join the conversation as they discuss how OCD presents across different patients, evidence-based treatment approaches, and the critical role clinicians play in helping individuals manage symptoms and work toward remission.  Jeffrey R. Strawn, MD, FAACAP is a Professor of Psychiatry, Pediatrics, and Clinical & Translational Pharmacology at the University of Cincinnati (UC) in Cincinnati, Ohio. He is the Director of the UC Anxiety Disorders Research Program and the Associate Vice Chair of Research in the Department of Psychiatry & Behavioral Neuroscience at UC.  Andrew J. Cutler, MD is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.  Never miss an episode!

[Rerun] Dr Kirk Honda talks with Dr Robert Grubbs about psychopharmacology, Ambien, truth serum, methadone, and over-prescribing. (Intro)This episode is sponsored by BetterHelp. Give online therapy a try at betterhelp.com/KIRK to get 10% off your first month.Become a member: https://www.youtube.com/channel/UCOUZWV1DRtHtpP2H48S7iiw/joinBecome a patron: https://www.patreon.com/PsychologyInSeattleEmail: https://www.psychologyinseattle.com/contactWebsite: https://www.psychologyinseattle.comMerch: https://psychologyinseattle-shop.fourthwall.com/Instagram: https://www.instagram.com/psychologyinseattle/Facebook Official Page: https://www.facebook.com/PsychologyInSeattle/TikTok: https://www.tiktok.com/@kirk.hondaOctober 12, 2016The Psychology In Seattle Podcast ®Trigger Warning: This episode may include topics such as assault, trauma, and discrimination. If necessary, listeners are encouraged to refrain from listening and care for their safety and well-being.Disclaimer: The content provided is for educational, informational, and entertainment purposes only. Nothing here constitutes personal or professional consultation, therapy, diagnosis, or creates a counselor-client relationship. Topics discussed may generate differing points of view. If you participate (by being a guest, submitting a question, or commenting) you must do so with the knowledge that we cannot control reactions or responses from others, which may not agree with you or feel unfair. Your participation on this site is at your own risk, accepting full responsibility for any liability or harm that may result. Anything you write here may be used for discussion or endorsement of the podcast. Opinions and views expressed by the host and guest hosts are personal views. Although, we take precautions and fact check, they should not be considered facts and the opinions may change. Opinions posted by participants (such as comments) are not those of the hosts. Readers should not rely on any information found here and should perform due diligence before taking any action. For a more extensive description of factors for you to consider, please see www.psychologyinseattle.com

Today, Dr. Andy Cutler interviews Dr. Katharine Phillips about identifying and treating body dysmorphic disorder (BDD). Join the discussion as they talk about how BDD presents, the treatments available for this debilitating disorder, and how clinicians can help their patients reach remission.  Katharine Phillips, MD is a renowned psychiatrist and leading authority on body dysmorphic disorder (BDD). She serves as Professor of Psychiatry and DeWitt Wallace Senior Scholar at Weill Cornell Medical College and is an attending psychiatrist at New York-Presbyterian Hospital.   Andrew J. Cutler, MD is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.    Resources  BDD Treatment Manuals International OCD Foundation - BDD     Never miss an episode!

In this episode of “Beyond the Pill: Demystifying Evidence, Numbers & Causation in Psychopharmacology,” we pull back the curtain on how psychiatric medications earn their stripes—and what their numbers really mean. You'll learn: • Why all studies aren't created equal, from meta-analyses and randomized controlled trials down to cohort studies and case reports, and the ethical or practical reasons behind each design. • How to interpret NNT (Number Needed to Treat) and NNH (Number Needed to Harm) so you can weigh benefits against risks in plain English. • The danger of assuming causation from correlation, illustrated by the classic post hoc ergo propter hoc fallacy—think ice cream sales and shark attacks—and how the Bradford Hill criteria help us tease out true cause-and-effect relationships.Whether you're a patient curious about why your psychiatrist chose a particular drug or a clinician sharpening your critical-thinking toolkit, this episode will give you the evidence-based perspective you need to make informed decisions—beyond the pill.

This episode includes extended Q&A sessions that address your unanswered questions from the following presentations delivered at the 2025 Spring Congress in Philadelphia, Pennsylvania:  (00:20) All the Tea on ADHD: Guidance for Developing Effective Treatment Strategies for Patients With ADHD by Andrew Cutler, MD   (20:20) You and I and an LAI: Benefits, Early Adoption, and Options for Patients With Serious Mental Illness Desiree Matthews, MSN, PMHNP-BC and Jonathan Meyer, MD (Q&A with Desiree Matthews)   (38:53) A Practical Guide to Ordering and Interpreting Kidney Function Tests by Rajnish Mago, MD   (59:13) Preventing the Progression From Casual to Casualty: An Update on Interventions for Substance Use Disorders by Hara Oyedeji, APRN, PMHNP-BC, MSN, MSEd and Andrew Cutler, MD (Q&A with Hara Oyedeji)    Never miss an episode!

Contact: mentalhealthctr.comRecovery literature (Quit-Lit) Recommendation: Motivational Interviewing: Helping People Change and Grow by William R. Miller PhD, Stephen Rollnick PhD - https://a.co/d/0e0LrSeSong that symbolizes Recovery to Mark: Eye of The Tiger by Survivor - https://youtu.be/btPJPFnesV4?si=ku4iDWLxrhyTUujhIn this episode of The Way Out Podcast, host Jason R.m engages in a deep conversation with Dr. Mark Hrymoc, a psychiatrist specializing in addiction. They explore the multifaceted nature of recovery,the intersection of addiction and mental health, and the importance of treating both simultaneously. Dr. Hrymoc shares insights on innovative treatments like ketamine therapy and the challenges of medications like Suboxone. The discussion also touches on personal reflections about family, success, and the ongoing journey of learning in both personal and professional realms. Dr. Hrymoc emphasizes the importance of reaching out for help and the value of support in the recovery process.TakeawaysRecovery means functioning optimally without limitationsfrom addiction.Addiction and mental health issues often feed off eachother.Both addiction and mental health need to be treatedsimultaneously.Ketamine therapy shows promise for treating depression andanxiety.Suboxone can be challenging to taper off, but a slowapproach can help.Psychopharmacology is focused on treating brain disorderswith medication.Addiction is a lifelong condition that requires management.Family dynamics play a crucial role in addiction recovery.It's important to model humility and communication inrelationships.Struggling with addiction is not a shameful experience. (c) 2015 - 2025 The Way Out Podcast | All Rights Reserved.ThemeMusic: “all clear”(⁠⁠⁠https://ketsa.uk/browse-music/)byKetsa(https://ketsa.uk⁠⁠⁠)licensedunderCCBY-NC-ND4.0(https://creativecommons.org/licenses/by-nc-nd)

Can medication truly transform the landscape of pediatric mental health, or are we oversimplifying the complexities of growing minds? In this episode of Pediatric Meltdown, Dr. Lia Gaggino welcomes Dr. Jess Pierce, a hospital-based child psychiatrist whose expertise bridges the worlds of pediatrics and mental health, especially for children in rural areas. Unraveling the fascinating history of psychopharmacology and delving into the mechanisms of action for the antidepressants, this episode offers a roadmap for pediatricians navigating the maze of SSRIs, SNRIs, risks like serotonin syndrome, and difficult conversations about side effects. The nuances matter and Dr. Pierce guides us skillfully.Discover why family history, patient buy-in, and transparent communications are pivotal to successful treatment—and why prescribing for young people demands a delicate blend of science, art, and empathy. This conversation will change the way you see—and approach—medication and the treatment of kids' mental health.[00:08:51] Exploring Pediatric Psychopharmacology's RootsTracing the unexpected origins of antidepressants, including how tuberculosis and hypertension treatments led to modern psychopharmacologyThe monoamine hypothesis: understanding the neurotransmitter focus in early depression treatmentsThe move beyond serotonin, dopamine, and norepinephrine: new research on neurobiology, neurogenesis, and stress responseProzac's arrival and its impact in reshaping the treatment landscape for pediatric mental health[08:52- 18:06 ] SSRIs in Practice: Similarities, Differences, and SelectionAll SSRIs share rapid absorption, high protein binding, and similar side effect profiles—but key differences can matterImportant reasons to avoid Paxil and to use Lexapro over Celexa, particularly due to side effect burdensNuanced considerations: matching specific SSRIs to individual patient needs, such as Prozac's activating profile for low-energy depressionPractical dosing strategies: the art of balancing “start low and go slow” with the urgency to help suffering children[18:07- 27:59] Navigating Risks, Side Effects, and Patient MonitoringThe truth behind the Black Box Warning: clarifying risks of suicidal ideation vs. the dangers of untreated depressionWhy regular, open conversations with families about medication side effects—especially sexual side effects in teens—build trust and adherenceRecognizing and managing serotonin syndrome: how to spot symptoms and when emergency intervention is neededIdentifying high-risk drug interactions, including situations with migraine or neurology medications[28:00-45:19 ] From SNRIs to the Five-Step Prescribing Approach and BeyondHow SNRIs differ from SSRIs in action, side effects, and indication—especially in pain syndromes or where activating effects are desiredThe use of Wellbutrin as an alternative with fewer sexual side effects, and cautions for seizure-prone populationsStrategic guidelines: the five-step approach to medication choice, considering patient history, family response, symptoms, buy-in, and comorbiditiesCritical cautions with genetic testing and the limitations of using these results to guide first-line medication choices[45:20-1:00:00] Dr Lia's TakeAwaysResources Mentioned:Dr. Pierce's PPT on Pediatric Psychopharmacology Hello! Here's the link to the slides: Psychopharm...

In this episode, Dr. Andy Cutler is joined by Dr. Jennifer Payne to discuss management of mood disorders influenced by fluctuations in reproductive hormones, particularly in women. They explore medication management during the perinatal period, emphasizing the risks associated with inadequately treated mood disorders. The conversation also addresses strategies for managing hormone-related mood disorders across reproductive stages, including premenstrual dysphoric disorder, premenstrual exacerbation, and perimenopausal depression. Jennifer L. Payne, MD is a psychiatrist specializing in reproductive psychiatry and mood disorders in women. She serves as Vice Chair of Research and Professor in the Department of Psychiatry and Neurobehavioral Sciences at the University of Virginia, directing the Reproductive Psychiatry Research Program.  Andrew J. Cutler, MD is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.

Episode 81 – Janice and Robbie's Story   Robbie is probably one of the most anxious dogs I have seen in my 6 years working as a Veterinary Psychiatrist. His behaviour got so bad that his lovely caregiver, Janice, had to sleep on the sofa with him for several weeks, neither of them getting much sleep. When I first met him, Robbie would pace, pant, patrol the home, lick walls and cupboards, and paw at the floor to try to make himself feel a little better. The relationship with his housemate dogs became extremely tense as they were just not able to read his body language or understand his behaviour. Everyone was stressed and at a loss.   After an initial consultation, I started Robbie on a comprehensive psychopharmaceutical treatment plan and within a few weeks, his anxiety had decreased to the point that Janice could sleep in her own bed again. Robbie continues to go from strength to strength and has even started to play with his toys again and is friends with his housemate dogs again.   Are you a pet parent in a similar situation? Then find me here: www.trinityvetbehaviour.com   Are you a Vet or Pet Care Professional who wants to learn more about Psychopharmacology? Then I have just the thing for you: PSYCHOACTIVE – PRACTICAL VETERINARY PSYCHOPHARMACOLOGY https://katrin-jahn.mykajabi.com/psychoactive   An online course dedicated to teaching you what you need to know to get started on your Veterinary Psychopharmacology Journey!   If you liked this episode of the show, The Pet Behaviour Chat, please LEAVE A 5-STAR REVIEW, like, share, and subscribe!   Facebook Group: Join The Pet Behaviour Community on Facebook   You can CONNECT with me: Website: Visit my website Trinity Veterinary Behaviour Instagram: Follow Trinity Veterinary Behaviour on Instagram Trinity Veterinary Behaviour Facebook: Join us on Trinity Veterinary Behaviour's Facebook page Trinity Veterinary Behaviour YouTube: Subscribe to Trinity Veterinary Behaviour on YouTube LinkedIn Profile: Connect with me on LinkedIn   Thank you for tuning in!

Join Dr. Andy Cutler and Dr. Cynthia Bulik as they discuss the challenges of diagnosing and treating binge eating disorder (BED). They explore the genetics, neurobiology, and clinical course of BED that inform treatment decisions, and examine how advances in genetic research and emerging pharmacological options may improve outcomes for individuals with BED.  Cynthia Bulik, PhD, FAED is a Distinguished Professor of Eating Disorders in the Department of Psychiatry, a Professor of Nutrition in the Gillings School of Global Public Health and the Founding Director of the Center of Excellence for Eating Disorders at the University of North Carolina at Chapel Hill.    Andrew J. Cutler, MD is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.    Resources  Eating Disorders Genetics Initiative (EDGI) 2 - edgi2.org  National Eating Disorders Association - nationaleatingdisorders.org  Families Empowered and Supporting the Treatment of Eating Disorders (FEAST) - feast-ed.org   

Are you feeling called to psychedelics? This is your official invitation to a psychedelic magic mushroom retreat with me in Mexico from Sep 10-16. Get all the details ⁠⁠here⁠⁠ and sign up for a free discovery call!My personal experiences with psychedelics have brought me so much healing and expansion! I've reversed my PTSD diagnosis, released shame and my inner critic, ignited my Intuition, and stepped into my power to create a life I LIKE. I share all those details in ep 242.Throughout most of human history, human beings believed in animism, and it doesn't contradict religion (or, it doesn't have to.)Animism is the belief that everything in Nature is alive and has a spirit or consciousness—not just humans and animals, but also trees, rivers, rocks, mountains, and even weather systems.It's one of the oldest belief systems in the world and is found in many Indigenous and earth-based traditions.Animism teaches that the world is made up of relationships - that we're in constant dialogue with the more-than-human world, and that everything is interconnected and deserving of respect.Animism invites us to…listen to and talk to Naturetreat Nature as kin, not a resourcelive in reciprocity, to give to Nature as well as receiveAnimism and relationship with Nature are always available to ALL of us. When we add psychedelics to the mix, especially ones derived from plants and fungi, our perception of how alive and relational Nature is becomes amplified. In a 2019 study published in Journal of Psychopharmacology, participants who took psilocybin (magic mushrooms) reported a 58% increase in their sense of connectedness to nature, and this feeling persisted even two weeks after the experience (Lyons & Carhart-Harris, 2019.) And this study was actually done in a clinical/medical setting, not even in Nature. Whether you're interested in psychedelics or not, this episode will help you deepen your connection to Nature, perfect timing to celebrate Earth Day!EARTH MAGIC WOMEN'S CIRCLEOn Earth Day - Tuesday 4/22 at 6 PM EST - we're having an Earth Magic Celebration on Zoom inside the Wild Wellness Women's Circle.We'll be talking about:myths and creation stories about the Earth being personal and relationalpractical and magical ways to be more connected with Nature - to receive physical and mental health benefits and also to receive messages from your Intuitionhow to see Nature as a mirror for what's happening in our inner world through its cycles of growth and restsome plant medicines and herbs that everyone can start working with, and I'll even pull a plant medicine oracle card personally for YOU!When you join the Wild Wellness Women's Circle…You'll automatically be emailed the Zoom link for this event, plus all upcoming events.You'll also get immediate access to all past live event records, all the self-paced resources, and our daily group chat.If you can't come live, you can watch the replays at YOUR most aligned time, and still make friends and connect in the group chat. Many of us do it this way!Join anytime. Cancel anytime. Name your own price if you need.Free Resources- Feel how you want to feel NOW with my ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Free Desire Map⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠- FREE Masterclass: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Discover Your Spiritual Gifts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠- Sign up for a FREE 1:1 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠coaching curiosity call⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Let's Connect on⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠!⁠⁠⁠⁠⁠

Episode 78 – Supporting Pets and Caregivers on their Medication Journey   What are some of the conversations I have with caregivers when it comes to deciding if psychotropic medication in an option for their beloved pet? And what do I discuss with them about the “onboarding” process? How do I manage their expectations and concerns? And what are some of their most frequent worries and how do I address these?   Find out all this an more in this episode!   Are you a Vet or Pet Care Professional who wants to learn more about Psychopharmacology? Then I have just the thing for you: PSYCHOACTIVE – PRACTICAL VETERINARY PSYCHOPHARMACOLOGY https://katrin-jahn.mykajabi.com/psychoactive   An online course dedicated to teaching you what you need to know to get started on your Veterinary Psychopharmacology Journey!   I really hope you enjoy this episode; it is packed with so much information!   If you liked this episode of the show, The Pet Behaviour Chat, please LEAVE A 5-STAR REVIEW, like, share, and subscribe!   Facebook Group: Join The Pet Behaviour Community on Facebook   You can CONNECT with me: Website: Visit my website Trinity Veterinary Behaviour Instagram: Follow Trinity Veterinary Behaviour on Instagram Trinity Veterinary Behaviour Facebook: Join us on Trinity Veterinary Behaviour's Facebook page Trinity Veterinary Behaviour YouTube: Subscribe to Trinity Veterinary Behaviour on YouTube LinkedIn Profile: Connect with me on LinkedIn   Thank you for tuning in!

Join Dr. Andy Cutler and Dr. Carla Sharp as they discuss the current conceptualization of borderline personality disorder (BPD), including diagnostic challenges, evidence-based treatments, and strategies to reduce stigma by framing BPD as a treatable condition. The conversation also covers recent updates to the APA's BPD guidelines.  Carla Sharp, PhD is a distinguished clinical psychologist specializing in developmental psychopathology, particularly borderline personality disorder (BPD). She is a professor in the Clinical Psychology Doctoral Program and serves as the Associate Dean for Faculty and Research at the University of Houston. Additionally, she directs both the Adolescent Diagnosis, Assessment, Prevention, and Treatment Center and the Developmental Psychopathology Lab at the university.   Andrew J. Cutler, MD is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.   

Episode 76 – Choosing Your Psychopharmacology Patient   Would you know which of your patients Behaviour Medication might be indicated for? What are the presentations that could benefit from Behaviour Meds? What are the contexts or situations that might also benefit from the safe and effective use of psychopharmacology?   Have a listen to this episode as I chat about some of the things I think about when evaluating my patients for the potential use of psychotropic medication. Because not every patient is suitable, but for those that are, these medications can be an absolute game changer!   Are you a Vet or Pet Care Professional who wants to learn more about Psychopharmacology? Then I have just the thing for you:   PSYCHOACTIVE – PRACTICAL VETERINARY PSYCHOPHARMACOLOGY https://katrin-jahn.mykajabi.com/psychoactive   An online course dedicated to teaching you what you need to know to get started on your Veterinary Psychopharmacology Journey! Get it at the pre-sale price of just 222 USD until April 24th, 2025 (regular price – 555 USD)   If you liked this episode of the show, The Pet Behaviour Chat, please LEAVE A 5-STAR REVIEW, like, share, and subscribe!   Facebook Group: Join The Pet Behaviour Community on Facebook   You can CONNECT with me: Website: Visit my website Trinity Veterinary Behaviour Instagram: Follow Trinity Veterinary Behaviour on Instagram Trinity Veterinary Behaviour Facebook: Join us on Trinity Veterinary Behaviour's Facebook page Trinity Veterinary Behaviour YouTube: Subscribe to Trinity Veterinary Behaviour on YouTube LinkedIn Profile: Connect with me on LinkedIn   Thank you for tuning in!

Join Dr. Andy Cutler as he speaks with Dr. Anita Clayton about one of the most common yet least discussed side effects of psychotropic medications—sexual dysfunction. They explore the different aspects of sexual dysfunction that may arise as a side effect, how to distinguish these from symptoms of psychiatric or medical disorders, and how to collaborate with patients to effectively address this challenging issue.  Anita H. Clayton, MD, Wilford W. Spradlin Professor and Chair of Psychiatry & Neurobehavioral Sciences, and Professor of Clinical Obstetrics & Gynecology at the University of Virginia School of Medicine, has focused her research on major depressive disorder, mood disorders associated with reproductive-life events in women (reproductive psychiatry), sexual dysfunction related to illness and medications, and the assessment and treatment of primary sexual disorders.    Andrew J. Cutler, MD is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.    Resources  Changes in Sexual Functioning Questionnaire short- form (CSFQ-14)  Validation study for CSFQ-14   

Professor David Taylor is Director of Pharmacy and Pathology at the Maudsley Hospital and Professor of Psychopharmacology at KCL. David is the Editor-in-Chief of the journal Therapeutic Advances in Psychopharmacology. Professor Taylor has been the lead author of the Maudsley Prescribing Guidelines since their inception in 1993. David has also authored over 375 clinical papers in journals such as the Lancet, BMJ, JAMA Psychiatry, British Journal of Psychiatry and Journal of Clinical Psychiatry. Today we discuss: - What the science says about the effectiveness of anti-depressants.- Evidence based principles for prescribing anti-depressants safely. - Common side effects and withdrawal symptoms. - Do anti-depressants work via so called "emotional numbing" effects?- The use of anti-depressants for other conditions such as OCD and PTSD. - Emerging treatments for depression such as ketamine and psilocybin. - New treatments for psychosis such as KarXT (Cobenfy). Interviewed by Dr. Alex Curmi. Dr. Alex is a consultant psychiatrist and a UKCP registered psychotherapist in-training.If you would like to invite Alex to speak at your organisation please email alexcurmitherapy@gmail.com with "Speaking Enquiry" in the subject line.Alex is not currently taking on new psychotherapy clients, if you are interested in working with Alex for focused behaviour change coaching , you can email - alexcurmitherapy@gmail.com with "Coaching" in the subject line.Give feedback here - thinkingmindpodcast@gmail.com - Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast Tiktok - @thinking.mind.podcast 

Join Dr. Andy Cutler as he speaks with Dr. Christine Moutier about the unintended effects of the FDA boxed warnings on antidepressant use in pediatric patients—specifically, the underdiagnosis and undertreatment of depression. Their conversation highlights the importance of effectively treating depression to reduce suicide across the lifespan.  Christine Yu Moutier, MD is a leading psychiatrist and the Chief Medical Officer at the American Foundation for Suicide Prevention (AFSP). Since joining AFSP in 2013, Dr. Moutier has led a nationwide movement combining scientific research and grassroots efforts to reduce suicide rates. She has testified before Congress, presented at the White House, and frequently contributes to major media outlets on mental health issues.   Andrew J. Cutler, MD is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.    Resources  American Foundation for Suicide Prevention - https://afsp.org/    Save $100 on registration for 2025 NEI Spring Congress with code NEIPOD25  Register today at nei.global/spcongress25f    Never miss an episode!

CONTÁCTAME POR WHATSAPP https://wa.me/message/VLBJNM7KBBQDC1 DÉJAME CONOCER TU CASO HACIENDO CLIC AQUÍ https://nelsonarturopsicologo.com/superar-ansiedad Así puedes subir la serotonina de manera natural; y es que, el acelerado ritmo de vida del siglo XXI ha conducido a una búsqueda constante de elementos que faciliten el tener una vida más tranquila, generalmente, bajar los niveles de ansiedad y estrés, poder dormir mejor, son cosas que sin duda se puede que nos haga falta, y para ello es necesario tener niveles estables de serotonina. Este neurotransmisor es el encargado del buen funcionamiento del cerebro aparte de las células nerviosas, permitiendo nivelar las emociones. Teniendo en cuenta estos efectos, hoy te contaremos como regular los niveles de serotonina mediante el suplemento 5HTP. ¿QUÉ ES EL 5 HTP? El 5 hidroxitriptófano popularmente conocido como 5HTP es un precursor de la serotonina, es decir, un elemento vital en la formación de este neurotransmisor. Compra el 5HTP https://iherb.co/Hct3Hehe Existen diversos métodos para su obtención, siendo el más común lógicamente la ingesta de alimentos ricos en él, como la carne de pavo, el pollo, los frijoles, la carne res y bananos; sin embargo, dado los hábitos de alimentación actuales, se ha vuelto complejo añadir alguno de los alimentos anteriormente mencionadas a la dieta diaria, por lo que, una opción para su obtenerlo es mediante la suplementación. ¿POR QUÉ NO SE CONSUME SEROTONINA DE FORMA DIRECTA? Al ser un neurotransmisor que es producido naturalmente por el cuerpo humano, la serotonina es muy diferente a cualquier consumible ya sea por ingesta o por medio intravenosos, la serotonina es incapaz de superar dos barreras de nuestro organismo, la que produce el ácido gástrico, y la producida por la red hematoencefálica. LA DOSIS IDEAL DE 5HTP Se recomienda generalmente. consumir alrededor de 300 mg al día de 5HTP, siempre y cuando la persona tenga características promedio, lo que permitirá producir la serotonina necesaria para contrarrestar afectaciones negativas, como la ansiedad, la falta de sueño, mientras permite gestionar de mejor forma el estrés y regular el apetito. Como ya se ha mencionado en entregas pasadas, para dosificar eficientemente cualquier suplemento es necesario tener presente la estatura, el peso y el problema que se quiere combatir; para mencionar una cosa, puedes contactar con nosotros en Libre de Ansiedad ya que podemos asesorarte si así lo requieres. Es importante señalar que los efectos no son inmediatos, ya que se estima que el 5HTP empieza a tener un impacto significativo en el organismo de una persona entre una a tres semanas de haber empezado la ingesta, ten en cuenta que, en el caso de este potenciador de serotonina, si bien existen testimonios sobre una supuesta efectividad inmediata, suelen ser casos aislados que no representan el efecto normal del suplemento. ENLACES DE INTERÉS (H3) TRIPTÓFANO Y 5HTP PARA CURAR LA ANSIEDAD Y OTROS TRASTORNOS (https://nelsonarturopsicologo.com/triptofano-y-5htp-para-curar-la-ansiedad-y-otros-trastornos/) 7 FORMAS DE SUBIR LA SEROTONINA NATURALMENTE, Y REDUCIR LA ANSIEDAD, LA DEPRESIÓN EL ESTRÉS Y SENTIRTE MEJOR (https://nelsonarturopsicologo.com/7-formas-de-subir-la-serotonina-naturalmente/) REFERENCIAS Boer, J., & Westenberg, H. (1990). Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder. Psychiatry Research, 31, 267-278. https://doi.org/10.1016/0165-1781(90)90096-N. Handley, S., & McBlane, J. (2005). 5HT drugs in animal models of anxiety. Psychopharmacology, 112, 13-20. https://doi.org/10.1007/BF02247358. Maffei, M. (2020). 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. International Journal of Molecular Sciences, 22. https://doi.org/10.3390/ijms22010181. Lesch, K., Bengel, D., Heils, A., Sabol, S., Greenberg, B., Petri, S., Benjamin, J., Müller, C., Hamer, D., & Murphy, D. (1996). Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region. Science, 274, 1527 - 1531. https://doi.org/10.1126/science.274.5292.1527.

Navigating Modern Mental Health: Integrative Psychiatry with Dr. Drew Ramsey, a leading board-certified integrative psychiatrist. The conversation addresses the pressing mental health crisis affecting all age groups, from rising Alzheimer's cases among seniors to increasing anxiety and depression in youth. Dr. Ramsey introduces his book, “Healing the Modern Brain: Nine Tenets to Build Mental Fitness and Revitalize Your Mind,” which emphasizes lifestyle changes over medication. They explore the significance of nutritional psychiatry, the effects of modern lifestyle challenges, and the essential tenets for mental fitness. Dr. Ramsey shares his clinical experiences, insights on the benefits of diverse diets, and stresses the importance of movement, purpose, and connection for mental health. The discussion also touches on the challenges and potential of the current health environment, advocating for a balanced and evidence-based approach to mental well-being.

Dr. Hoffman continues his conversation with Drew Ramsey, MD, a leading board-certified integrative psychiatrist and author of "Healing the Modern Brain: Nine Tenets to Build Mental Fitness and Revitalize Your Mind."

Join Dr. Andy Cutler as he talks with Dr. Jeffrey Strawn about how clinicians can determine the appropriate scenarios for benzodiazepine deprescribing, best practices for benzodiazepine tapering, and how to balance patient preferences to ensure best outcomes.  Jeffrey R. Strawn, MD is a Professor and Associate Vice Chair of Research in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati (UC) College of Medicine, the Assistant Director of Clinical and Translational Research in the Center for Clinical & Translational Science and Training at UC, and an Associate Professor in the Department of Pediatrics at UC and Cincinnati Children's Hospital Medical Center.   Andrew J. Cutler, MD is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.  Save $100 on registration for 2025 NEI Spring Congress with code NEIPOD25  Register today at nei.global/spcongress25p  Never miss an episode!

In this episode of our special pediatric psychopharmacology series, Dr. Jeffrey Strawn and Dr. Katherine Dahlsgaard review how psychiatric prescribers can incorporate cognitive behavioral therapy (CBT) practices into medication checks with pediatric patients who have anxiety disorders. Specifically, they discuss the importance of using exposures to reduce avoidance behaviors that are characteristic of and feed anxiety disorders. Jeffrey R. Strawn, MD is a Professor and Associate Vice Chair of Research in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati (UC) College of Medicine, the Assistant Director of Clinical and Translational Research in the Center for Clinical & Translational Science and Training at UC, and an Associate Professor in the Department of Pediatrics at UC and Cincinnati Children's Hospital Medical Center. Katherine Dahlsgaard, PhD, ABPP is a licensed clinical psychologist in Philadelphia, Pennsylvania with expertise in CBT for children, adolescents, and adults. Dr. Dahlsgaard specializes in evidence-based assessment and treatment of anxiety and related disorders.   Save $100 on registration for 2025 NEI Spring Congress with code NEIPOD25 Register today at nei.global/spcongress25a   Never miss an episode!

In this episode of Daily Value, we look at the relationship between genetics, habitual caffeine intake, and cognitive performance, using insights from a recent study (PMID: 39648354) in the Journal of Psychopharmacology. Whether you're a "fast" or "slow" caffeine metabolizer could significantly influence how caffeine impacts your brain.Discussion Points:Gene-Caffeine Interactions: how variants in CYP1A2 and ADORA2A genes modulate caffeine metabolism and sensitivity, leading to differential effects on executive function and social cognition.Cognitive Domains: Why slow metabolizers consuming high caffeine outperform fast metabolizers in emotion recognition tasks, and why moderate caffeine enhances executive function in fast metabolizers.Practical Applications: Tailoring caffeine intake based on genetic predisposition to optimize focus, decision-making, and cognitive flexibility.https://pubmed.ncbi.nlm.nih.gov/39648354/Support the show

Join Dr. Andy Cutler as he talks with Dr. Descartes Li about the facts and fiction of electroconvulsive therapy (ECT). They discuss the efficacy and potential side effects of ECT, as well as the importance of educating patients and clinicians on ECT in order to overcome stigma associated with this life-saving treatment.   Descartes Li, MD is a psychiatrist who specializes in caring for patients with bipolar disorder and patients receiving electroconvulsive therapy. He directs the UCSF Bipolar Disorders Program and the UCSF Electroconvulsive Therapy Program. Dr. Li's research interests include bipolar disorder, electroconvulsive therapy and medical education.    Resources  University of California, San Francisco ECT FAQ    Save $100 on registration for 2025 NEI Spring Congress with code NEIPOD25  Register today at nei.global/spcongress25f    Never miss an episode!

In this special episode, we present highlights from the PsychopharmaStahlogy Show, hosted by Dr. Andy Cutler and featuring Dr. Stephen Stahl. Join us as we share clips from the most popular episodes of the series, showcasing some of the most though-provoking moments. (01:13) Clip from Treating ADHD Across the Lifespan with Dr. David Goodman (16:16) Clip from Management of Complex Treatment-Resistant Psychotic Disorders with Dr. Michael Cummings (29:31) Clip from Underutilized Psychiatric Drugs: Lithium with Dr. Jonathan Meyer (42:50) Clip from The Antisocial Personality Disorder Spectrum: Diagnosis and Treatment with Dr. James Knoll Save $100 on registration for 2025 NEI Spring Congress with code NEIPOD25 Register today at nei.global/spcongress25f Never miss an episode!

In this episode of our special pediatric psychopharmacology series, Dr. Jeffrey Strawn and Dr. Robyn Thom discuss the situations in which psychotropic medications are appropriate for children with autism spectrum disorder. They also explore strategies for managing side effects of these medications, including cases involving polypharmacy in this population.   Jeffrey R. Strawn, MD is a Professor and Associate Vice Chair of Research in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati (UC) College of Medicine, the Assistant Director of Clinical and Translational Research in the Center for Clinical & Translational Science and Training at UC, and an Associate Professor in the Department of Pediatrics at UC and Cincinnati Children's Hospital Medical Center.  Robyn Thom, MD is an Assistant Professor at Harvard Medical School and a staff psychiatrist at the Massachusetts General Hospital Lurie Center for Autism. Dr. Thom specializes in treating children and adults with autism spectrum disorder and other neurodevelopmental disorders, anxiety disorders, and mood disorders.  Save $100 on registration for 2025 NEI Spring Congress with code NEIPOD25 Register today at https://nei.global/spcongress25p Never miss an episode!

In this episode, we explore the critical role of therapeutic alliance in psychopharmacology. We discuss how factors like empathy, communication, and shared decision-making can significantly impact treatment outcomes. Did you know that a doctor's warm voice can increase appointment adherence by 162%? Faculty: David Mintz, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Psychodynamic Psychopharmacology: Alliance, Communication, and Psychotherapy Skills Pharmacotherapy Alliance, Treatment Preferences, and Communication

Visit SetSet's website ⁠⁠here⁠⁠, enter 3FOR2 at checkout, and get a deck of cards for free when you buy 2 decks through Christmas Day 2024. You can also find these clinician-backed resources on psilocybin: ⁠The Ultimate Psilocybin Guide⁠ ⁠Micro-Psyched 12-week Microdosing Program⁠"How can microdosing foster personal growth and self-compassion?" In this episode, April Pride continues her conversation with Amy Wong, who introduces her book, Small Doses of Awareness, co-authored with Shin Yi Pei. Amy discusses how microdosing can support mindfulness and emotional balance and provides insights into the practice of cultivating "small doses of awareness" through her guided journal. This episode offers practical guidance on microdosing, ancestral healing, and the spiritual dimensions of psychedelic work.After listening to this episode, you'll understand more about: The benefits of microdosing for mindfulness and emotional resilience How to integrate microdosing practices into daily life Insights from Small Doses of Awareness, a microdosing guided journal The role of self-compassion and self-awareness in psychedelic healingResources More information about Amy's clinical and psychedelic offerings. LINK Order Small Doses of Awareness: A Microdosing Companion LINK Materials referenced in this episode:  2021 Study: Single-blinded) Self-blinding citizen science to explore psychedelic microdosing (Balázs Szigeti, Laura Kartner, Allan Blemings, Fernando Rosas, Amanda Feilding, David J Nutt, Robin L Carhart-Harris, David Erritzoe (2021) Self-blinding citizen science to explore psychedelic microdosing eLife 10:e62878. DOI:  https://doi.org/10.7554/eLife.62878) 2023 Review: Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins(Rouaud, A., Calder, A. E., & Hasler, G. (2024). Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins. Journal of Psychopharmacology, 02698811231225609. DOI: https://doi.org/10.1177/02698811231225609) 2020 Survey: Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities (Anderson et al), Journal of Pharmacology , University of Toronto(Rosenbaum, D., Weissman, C., Anderson, T., Petranker, R., Dinh-Williams, L. A., Hui, K., & Hapke, E. (2020). Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities. Journal of Psychopharmacology, 34(6), 612-622. DOI: https://doi.org/10.1177%2F0269881120908004) 2019 Survey: Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers(Hutten, N. R. P. W., Mason, N. L., Dolder, P. C., & Kuypers, K. P. C. (2019). Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers. Frontiers in psychiatry, 10, 672. https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2019.00672/full)WEB | getsetset.comIG | @getsetsetYouTube | youtube.com/@getsetset Get full access to SetSet with April Pride at aprilpride.substack.com/subscribe

Visit SetSet's website ⁠here⁠, enter 3FOR2 at checkout, and get a deck of cards for free when you buy 2 decks through Christmas Day 2024. You can also find these clinician-backed resources on psilocybin: The Ultimate Psilocybin Guide Micro-Psyched 12-week Microdosing Program"What can MDMA and other psychedelics offer those healing from trauma?" In this episode, April Pride talks with Amy Wong, a licensed clinical social worker and MDMA-assisted therapist, about the profound therapeutic benefits of psychedelics. Amy shares her journey into psychedelic therapy and her work in helping clients transform through carefully guided MDMA and psilocybin experiences. This episode focuses on the impact of MDMA in treating trauma and the challenges surrounding policy and legalization in the psychedelic space.After listening to this episode, you'll understand more about: How MDMA can aid in trauma recovery and emotional processing The role of therapy and guidance in effective psychedelic experiences Key policy challenges and legal considerations in psychedelic therapy Amy's experiences and insights from working as an MDMA-assisted therapistResources More information about Amy's clinical and psychedelic offerings. LINK Order Small Doses of Awareness: A Microdosing Companion LINK Materials referenced in this episode:  2021 Study: Single-blinded) Self-blinding citizen science to explore psychedelic microdosing (Balázs Szigeti, Laura Kartner, Allan Blemings, Fernando Rosas, Amanda Feilding, David J Nutt, Robin L Carhart-Harris, David Erritzoe (2021) Self-blinding citizen science to explore psychedelic microdosing eLife 10:e62878. DOI:  https://doi.org/10.7554/eLife.62878) 2023 Review: Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins(Rouaud, A., Calder, A. E., & Hasler, G. (2024). Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins. Journal of Psychopharmacology, 02698811231225609. DOI: https://doi.org/10.1177/02698811231225609) 2020 Survey: Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities (Anderson et al), Journal of Pharmacology , University of Toronto(Rosenbaum, D., Weissman, C., Anderson, T., Petranker, R., Dinh-Williams, L. A., Hui, K., & Hapke, E. (2020). Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities. Journal of Psychopharmacology, 34(6), 612-622. DOI: https://doi.org/10.1177%2F0269881120908004) 2019 Survey: Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers(Hutten, N. R. P. W., Mason, N. L., Dolder, P. C., & Kuypers, K. P. C. (2019). Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers. Frontiers in psychiatry, 10, 672. https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2019.00672/full)WEB | getsetset.comIG | @getsetsetYouTube | youtube.com/@getsetset Get full access to SetSet with April Pride at aprilpride.substack.com/subscribe

Join Drs. Andy Cutler and Roger McIntyre as they discuss the most significant advancements in psychopharmacology over the past year. Their conversation highlights groundbreaking developments and innovations in the field of psychiatry.  Resources  This Month in Psychopharmacology  Never miss an episode!

In this episode, we explore the science behind the art of psychopharmacotherapy with Dr. David Mintz. We delve into how psychosocial factors, including the prescriber's approach, can significantly impact medication outcomes. Did you know that some psychiatrists achieve better results with placebos than others do with active medications? Faculty: David Mintz, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Psychodynamic Psychopharmacology: Alliance, Communication, and Psychotherapy Skills The Science of the Art of Psychopharmacotherapy

In this episode, I dive deep into the fascinating intersections of science and spirituality. Are we all connected in ways that go beyond what we can see or measure? From the mysteries of quantum physics and consciousness studies to the neuroscience behind meditation and near-death experiences, I explore how science is beginning to reveal insights that resonate with ancient spiritual teachings. Join me as I discuss the interconnected nature of reality, the potential for meditation to rewire the brain, and groundbreaking studies on consciousness that challenge conventional ideas about the mind. Whether you're a science enthusiast, a spiritual seeker, or just curious, this episode offers a fresh perspective on the big questions about life, connection, and the universe. References: Quantum Physics and Consciousness: Bohm, David. Wholeness and the Implicate Order. Routledge, 1980. Schrödinger, Erwin. What is Life? Mind and Matter. Cambridge University Press, 1944. Meditation and Neuroplasticity: Lazar, Sara W., et al. "Meditation experience is associated with increased cortical thickness." NeuroReport, 2005. Davidson, Richard J. Alterations in brain and immune function produced by mindfulness meditation. Psychosomatic Medicine, 2003. Consciousness Studies and Near-Death Experiences: Van Lommel, Pim. Consciousness Beyond Life: The Science of the Near-Death Experience. HarperOne, 2010. Psychedelic Studies: Griffiths, Roland R., et al. "Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer." Journal of Psychopharmacology, 2016. Learn more about your ad choices. Visit megaphone.fm/adchoices

The prevailing model of psychiatric care in the US is called "med management"-- this typically means a 10-15min appointment to review symptoms and choose medications.  Here Dr. Will Van Derveer of the Integrative Psychiatric Institute sits down with Dr. H to deconstruct this deeply flawed model and posit a more holistic and hopeful way of thinking about psychiatric care. Dr. Van Derveer and the Integrative Psychiatric Institutehttps://psychiatryinstitute.com/BFTA/ Dr. Hhttps://www.craigheacockmd.com/podcast-page/